Senior Care Records.

Facility Evaluation Report

Oakmont Gardens, Santa Rosa08/09/2024Licence 496803998

Capacity79
Date signed08/09/2024 02:31:00 PM
The inspector’s account

At approximately 12:15pm, Licensing Program Analyst (LPA) Christi Coppo arrived announced to conduct a case management visit in regards to an incident report submitted to CCL on 7/19/2024.

On 7/19/2024 the facility submitted to CCL an Incident report indicating a medication error had occurred at the facility. On 7/16/2024, facility began helping R1 with self-administration of medications. Incident report explains that at approximately 1:30am on 7/18/2024 resident (R1) reported to NOC shift caregiver (S1) needing their PRN pain medication. R1 has a physician's order for PRN Tramadol and scheduled Gabapentin. At this time, a Medication Technician (Med Tech) was not on schedule for the NOC shift, so S1 located the medication from the medication cart and provided it to R1. At approximately 6:00am, S1 reported to the oncoming day shift Med Tech (S2) that they had provided R1 with their PRN Tramadol and their scheduled Gabapentin.

S2 immediately report the incident to Health and Wellness Director (HWD). HWD then notified R1's responsible party and advised them of the incident. HWD also contacted Kaiser help line and left a message for R1's doctor. HWD left message for doctor and also sent over a fax indicating R1's medication error and inquiring as to a possible change in medication timing. Per R1's responsible party, the doctor was supposed to change the Gabapentin prescription from being scheduled every 4 hours to every 6 hours. HWD requested R1's responsible party to also follow up with doctor as HWD had not received a response back or call back from R1's doctor.

R1 did not exhibit any adverse reactions from the 1:30am dose of the PRN Tramadol and Gabapentin. Per R1's responsible party, the resident was believed to be self-administering the Gabapentin during these early morning hours prior to facility's start of helping R1 with their medication. LPA confirmed R1 still has not exhibited any adverse reactions stemming from medication error.

Source: California Department of Social Services, Community Care Licensing. Methodology · Report a correction